Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michihiko Aoyama
Institutions:
National Institute of Health Sciences,
National Institute of Health Sciences
Observed institutions:
National Institute of Health Sciences,
National Institute of Health Sciences,
The University of Osaka
ORCID:
0009-0007-7049-7541
Observed ORCID:
0009-0007-7049-7541
OpenAlex ID:
A5072837384
Works
28
Awards
2
Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates
2021
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Pharmaceutical Research
·
99
PDF
Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes
2016
·
Michihiko Aoyama
, Katsutomo Hata
, et al.
·
Biochemical and Biophysical Research Communications
·
94
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
2019
·
Michihiko Aoyama
, Noritaka Hashii
, et al.
·
mAbs
·
79
Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice
2015
·
Tokuyuki Yoshida
, Yasuo Yoshioka
, et al.
·
Nanotechnology
·
59
Human Scavenger Receptor A1-Mediated Inflammatory Response to Silica Particle Exposure Is Size Specific
2017
·
Nobuo Nishijima
, Toshiro Hirai
, et al.
·
Frontiers in Immunology
·
55
PDF
Fcγ Receptor Activation by Human Monoclonal Antibody Aggregates
2019
·
Minoru Tada
, Michihiko Aoyama
, et al.
·
Journal of Pharmaceutical Sciences
·
29
PDF
Intracellular trafficking of particles inside endosomal vesicles is regulated by particle size
2017
·
Michihiko Aoyama
, Yasuo Yoshioka
, et al.
·
Journal of Controlled Release
·
25
Characterization of Aggregated Antibody-Silicone Oil Complexes: From Perspectives of Morphology, 3D Image, and Fcγ Receptor Activation
2020
·
Masato Kiyoshi
, Minoru Tada
, et al.
·
Journal of Pharmaceutical Sciences
·
18
Strategic design of GalNAc-helical peptide ligands for efficient liver targeting
2024
·
Takahito Ito
, Nobumichi Ohoka
, et al.
·
Chemical Science
·
15
PDF
Linker and Conjugation Site Synergy in Antibody–Drug Conjugates: Impacts on Biological Activity
2024
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Bioconjugate Chemistry
·
14
Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics
2023
·
Masato Kiyoshi
, Makoto Nakakido
, et al.
·
Scientific Reports
·
13
PDF
Silver Nanoparticles Induce DNA Hypomethylation through Proteasome-Mediated Degradation of DNA Methyltransferase 1
2020
·
Ayaka Maki
, Ying Lin
, et al.
·
Biological and Pharmaceutical Bulletin
·
9
PDF
Effects of amino acid substitutions on the biological activity of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
2018
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Biochemical and Biophysical Research Communications
·
9
Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in Japan
2020
·
Akiko Ishii-Watabe
, Hiroko Shibata
, et al.
·
Journal of Pharmaceutical Sciences
·
8
A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal Antibodies
2018
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Methods in molecular biology
·
6
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex
2023
·
Minoru Tada
, Michihiko Aoyama
, et al.
·
mAbs
·
5
PDF
Target-independent Immune-cell Activation by Aggregates of T Cell-redirecting Bispecific Antibodies
2023
·
Minoru Tada
, Michihiko Aoyama
, et al.
·
Journal of Pharmaceutical Sciences
·
4
PDF
FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassay
2022
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Biochemical and Biophysical Research Communications
·
4
PDF
Key Role of Pro230 in the Hinge Region on the Architecture and Function of IgG1
2026
·
Yuuki Koseki
, Yuki Yamaguchi
, et al.
·
Journal of Medicinal Chemistry
·
1
Correction: Strategic design of GalNAc-helical peptide ligands for efficient liver targeting
2025
·
Takahito Ito
, Nobumichi Ohoka
, et al.
·
Chemical Science
·
1
PDF
Perspectives on the Future of Antibody Therapeutic Use for the Prevention and Treatment of Infectious Diseases
2026
·
Minoru Tada
, Michihiko Aoyama
, et al.
·
YAKUGAKU ZASSHI
PDF
Correction to “Linker and Conjugation Site Synergy in Antibody–Drug Conjugates: Impacts on Biological Activity”
2026
·
Michihiko Aoyama
, Minoru Tada
, et al.
·
Bioconjugate Chemistry
Author response for "Strategic Design of GalNAc-Helical Peptide Ligands for Efficient Liver Targeting"
2024
·
Takahito Ito
, Michihiko Aoyama
, et al.
·
Publons reviews and discussion
Strategies for designing hepatocyte-selective carriers using helical peptides as stable scaffolds
2024
·
Takahito Ito
, Takashi Misawa
, et al.
·
European Peptide Symposium (EPS)
PDF
FcγRIIIa polymorphism affects the analytical performance of ADCC bioassay
2020
·
Michihiko Aoyama
·
The Pharmaceutical Society of Japan
Show more works
View as search
Works count:
28
Citation count:
547
H-index:
11
I10-index:
11
Year
Topic
Type